Search:
This item requires a subscription.
Effect of inhaled corticosteroids on bone RDIP, Volume 18, Number 4.
Current guidelines for the management of asthma advocate early intervention with inhaled corticosteroids.1 These agents are also widely used in the management of chronic obstructive pulmonary disease (COPD). Three compounds are licensed in the UK; beclometasone dipropionate (BDP), budesonide (BUD) and fluticasone propionate (FP).
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.